Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Guidelines
AUA guidelines are the trusted standard for clinical decision-making in urology, developed through a rigorous, evidence-based process that includes systematic literature reviews, graded evidence assessment, and expert panel oversight. To ensure the guidelines' integrity and responsible use, access now requires a login. If you do not have an account, you can create one for free.
New Updates to Disorders of Ejaculation Guideline
The role of the clinician in managing premature ejaculation and delayed ejaculation is to conduct appropriate investigation, provide education and reassurance, and offer available treatments that are rational and based on sound scientific data. This Guideline recommends shared decision-making as fundamental in the management of disorders of ejaculation; involvement of sexual partner(s) in decision making, when possible, may allow for optimization of outcomes.
Latest Guidelines
Non-Muscle Invasive Bladder Cancer Guideline
The recurrence and progression probability rates depend on several clinical and pathologic factors. Therefore, the ability to predict risk of recurrence and progression and treating non-muscle invasive bladder cancer (NMIBC) appropriately is important. This Guideline provides a risk-stratified clinical framework for the management of NMIBC.
Medical Management of Kidney Stones: AUA Guideline (2026)
The purpose of this Guideline is to provide a clinical framework for the diagnosis, treatment, prevention, and follow-up of adult and pediatric patients with kidney stones based on the best available published literature.
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026)
This new guideline provides a useful reference for an evidence-based approach to the management of LUTS/BPH.
Advanced Prostate Cancer: AUA/SUO Guideline (2026)
The management of advanced prostate cancer is rapidly evolving. To assist in clinical decision-making, evidence-based guideline statements were developed to provide a rational basis for evidence-based treatment. This guideline covers advanced prostate cancer, including disease stages that range from prostate-specific antigen (PSA) recurrence after exhaustion of local treatment options to widespread metastatic disease.